mating type switching donor selection

Known as: donor selection 
The process that determines which donor locus a cell uses, in preference to another, in mating type switching. [GOC:mah, PMID:9928492]
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mating type switching

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.
Life-threatening graft-versus-host disease (GVHD) limits the use of HLA-C-mismatched unrelated donors in transplantation… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.
Killer-cell immunoglobulin-like receptor (KIR) genes form a diverse, immunogenetic system. Group A and B KIR haplotypes have… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana.
Blood transfusion is an important mode of transmission of infections to recipients. The aim of the study was to assess the… (More)
Is this relevant?
2008
2008
Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype.
Stem cell transplantation across HLA barriers may trigger NK cell-mediated graft-vs-leukemia effects leading to improved survival… (More)
Is this relevant?
2006
2006
Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood units.
INTRODUCTION The main limitation factor for wide use of umbilical cord blood units (UCBs) as a source of hematopoietic… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
OBJECTIVE Optimizing cord blood donor selection based mainly on cell dose and human leukocyte antigen (HLA) disparities may… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Updated definitions of healthy ranges for serum alanine aminotransferase levels.
Context Current upper limits (500 nkat/L [30 U/L] for women, 667 nkat/L [40 U/L] for men) for serum alanine aminotransferase (ALT… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2002
2002
Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
Human leukocyte antigen (HLA) incompatibilities are the most important immunological barriers to bone marrow transplant success… (More)
Is this relevant?
1998
1998
Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection.
In comparison with HLA-matched sibling bone marrow transplants, unrelated donor transplants are associated with increased graft… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
1997
Review
1997
Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy.
Bone marrow transplantation (BMT) is the present treatment for hematological malignancies. Two major drawbacks of allogeneic BMT… (More)
  • figure 1
  • table 3
  • table 4
  • table 4
  • table 5
Is this relevant?